Incorporation of PET scanning into contemporary management programs for Hodgkin’s disease

Published: June 8, 2009
Abstract Views: 133
Untitled (): 0
PDF: 174
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

In just the past decade, positron emission tomography with fluorine-18 fluorodeoxyglucose (PET scanning) has come to be considered an essential component of initial staging of Hodgkin’s disease (HD) at many medical centers around the world. In addition, it is common to utilize PET scanning to evaluate response to treatment and to employ it as a component of routine surveillance programs.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Supporting Agencies

How to Cite

Hoppe, R. (2009). Incorporation of PET scanning into contemporary management programs for Hodgkin’s disease. Hematology Meeting Reports (formerly Haematologica Reports), 2(7). https://doi.org/10.4081/hmr.v2i7.400